

Weighing Up Diet Drugs
May 14, 2024
David Aaronovitch and Dr Ellie discuss the potential benefits of obesity jabs in reducing heart attack risks. They also talk about the new Co-op Live arena and its impact on the music industry. The podcast explores the journey of semaglutide from a diabetes drug to a weight loss wonder, highlighting regulatory challenges and the need for further research.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 2min
Semaglutide: From Diabetes Treatment to Weight Loss Wonder Drug
01:32 • 11min
Redefining Obesity: Beyond Willpower and Medication
12:07 • 4min
Exploring Personal Experiences with a Weight Loss Drug
16:18 • 2min
Personal Reflections on Weight Loss and Health Habits
18:23 • 2min
Live Music Venues: Challenges and Evolution
19:58 • 15min
Royal Event Excitement and Maternal Health Awareness
34:37 • 2min